BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24384116)

  • 1. Ischemia/reperfusion injury: effect of simultaneous inhibition of plasma cascade systems versus specific complement inhibition.
    Duehrkop C; Rieben R
    Biochem Pharmacol; 2014 Mar; 88(1):12-22. PubMed ID: 24384116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel interpretation of immune redundancy and duality in reperfusion injury with important implications for intervention in ischaemic disease.
    Thrane AS; Skehan JD; Thrane PS
    Med Hypotheses; 2007; 68(6):1363-70. PubMed ID: 17169498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of complement and perspectives for intervention in transplantation.
    Chen G; Chen S; Chen X
    Immunobiology; 2013 May; 218(5):817-27. PubMed ID: 23182708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation and inhibition in myocardial ischemia and reperfusion injury.
    Homeister JW; Lucchesi BR
    Annu Rev Pharmacol Toxicol; 1994; 34():17-40. PubMed ID: 8042849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of complement and perspectives for intervention in ischemia-reperfusion damage.
    Banz Y; Rieben R
    Ann Med; 2012 May; 44(3):205-17. PubMed ID: 21254897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Complement Drives Increase in Early Growth Response Proteins and Neuroprotection Mediated by Salidroside After Cerebral Ischemia.
    Lai W; Xie X; Zhang X; Wang Y; Chu K; Brown J; Chen L; Hong G
    Inflammation; 2018 Mar; 41(2):449-463. PubMed ID: 29198014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischaemia-reperfusion is an event triggered by immune complexes and complement.
    Chan RK; Ibrahim SI; Verna N; Carroll M; Moore FD; Hechtman HB
    Br J Surg; 2003 Dec; 90(12):1470-8. PubMed ID: 14648724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting the complement system does not reduce injury in renal ischemia reperfusion.
    Park P; Haas M; Cunningham PN; Alexander JJ; Bao L; Guthridge JM; Kraus DM; Holers VM; Quigg RJ
    J Am Soc Nephrol; 2001 Jul; 12(7):1383-1390. PubMed ID: 11423567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the complement cascade in ischemia/reperfusion injury: implications for neuroprotection.
    D'Ambrosio AL; Pinsky DJ; Connolly ES
    Mol Med; 2001 Jun; 7(6):367-82. PubMed ID: 11474130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the plasma cascade systems in ischemia/reperfusion injury of bone.
    Zhang S; Wotzkow C; Bongoni AK; Shaw-Boden J; Siegrist M; Taddeo A; Blank F; Hofstetter W; Rieben R
    Bone; 2017 Apr; 97():278-286. PubMed ID: 28159709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1 esterase inhibitor reduces lower extremity ischemia/reperfusion injury and associated lung damage.
    Duehrkop C; Banz Y; Spirig R; Miescher S; Nolte MW; Spycher M; Smith RA; Sacks SH; Rieben R
    PLoS One; 2013; 8(8):e72059. PubMed ID: 23991040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dextran sulfate modulates MAP kinase signaling and reduces endothelial injury in a rat aortic clamping model.
    Banz Y; Gajanayake T; Matozan K; Yang Z; Rieben R
    J Vasc Surg; 2009 Jul; 50(1):161-70. PubMed ID: 19563964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings.
    Keshavjee S; Davis RD; Zamora MR; de Perrot M; Patterson GA
    J Thorac Cardiovasc Surg; 2005 Feb; 129(2):423-8. PubMed ID: 15678055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APT070 (Mirococept), a membrane-localised complement inhibitor, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury.
    Souza DG; Esser D; Bradford R; Vieira AT; Teixeira MM
    Br J Pharmacol; 2005 Aug; 145(8):1027-34. PubMed ID: 15951831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes.
    Park P; Haas M; Cunningham PN; Bao L; Alexander JJ; Quigg RJ
    Am J Physiol Renal Physiol; 2002 Feb; 282(2):F352-7. PubMed ID: 11788450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle.
    Pemberton M; Anderson G; VÄ•tvicka V; Justus DE; Ross GD
    J Immunol; 1993 Jun; 150(11):5104-13. PubMed ID: 8496606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The complement system: an old story or target of new therapeutic approaches?].
    Heller A; Koch T
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2000 Apr; 35(4):207-13. PubMed ID: 10830072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlling the complement system in inflammation.
    Kirschfink M
    Immunopharmacology; 1997 Dec; 38(1-2):51-62. PubMed ID: 9476114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic inhibition of the complement system. Y2K update.
    Asghar SS; Pasch MC
    Front Biosci; 2000 Sep; 5():E63-81. PubMed ID: 10966868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation.
    De Vries B; Matthijsen RA; Wolfs TG; Van Bijnen AA; Heeringa P; Buurman WA
    Transplantation; 2003 Feb; 75(3):375-82. PubMed ID: 12589162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.